Courtagen Life Sciences was prominently featured in Wednesday's PBS News Hour as part of their story on medical cannabis research.
The piece, produced by science correspondent Miles O’Brien, opens with the story of Isaias Lopez, a 5-year-old boy with Dravet Syndrome. Isaias treats his seizures with CBD, a non-psychoactive chemical compound found in cannabis, and the results are amazing. Since he began taking CBD oil, his seizures have been reduced by 80%. In the video below, you will see his dramatic improvement.
Dravet Syndrome is one of the many seizure disorders Courtagen is able to help diagnose as part of our epiSEEK® gene panel, which identifies rare seizure causing variants. Anecdotal evidence has shown CBD to be an effective treatment for Dravet and a number of other rare seizure disorders. The GW Pharmaceuticals study, featured in the piece, is attempting to establish more scientific evidence around the effectiveness of CBD. Courtagen is working alongside the GW Pharmaceuticals study to look for genetic markers in the patients that may indicate responsiveness to the drug.
The piece also features comments from our Chief Scientific Officer, Kevin McKernan, as he explains the work Courtagen and Medicinal Genomics are doing to better understand the genetics of the cannabis plant. Medicinal Genomics has sequenced more than 600 cannabis strains in hopes of identifying the genes that are responsible for producing levels the cannabinoids and terpenoids found in the plant.
Check out the video below, and don't forget to tune in next Wednesday for part two of the story, which will feature footage from the CannMed conference and an interview with Dr. Raphael Mechoulam.